4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000072
EVP, Chief Business Officer sold 2,024 shares at $50.42 ($102,044)
- EVP, Chief Business Officer acquired 5,041 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form | +3,688 | 14,259 | D | ||
| 2024-01-17 | Sale : show line 2 in the form | −1,460 | $50.42 | $73,609 | 12,799 | D |
| 2024-01-16 | Exercise or conversion : show line 3 in the form | +1,353 | 2,204 | I | ||
| 2024-01-17 | Sale : show line 4 in the form | −564 | $50.42 | $28,435 | 1,640 | I |
| Open-market sales · 2,024 sh · avg $50.42 · $102,044 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −3,688 | $0.00 | 3,688 | 63,973 | D |
| 2024-01-16 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −1,353 | $0.00 | 1,353 | 7,034 | I |
Loading xslF345X05/edgardoc.xml…